NPR: AIPAC Halts Endorsements and Direct Contributions To Candidates
Whitepill.
NPR:
“The pro-Israel political organization AIPAC, or the American Israel Public Affairs Committee, announced on Wednesday that it will no longer issue endorsements, make direct PAC contributions or earmark funds for candidates.
A longtime influential lobbying group, AIPAC started its direct political involvement five years ago. Since then, particularly this midterm election cycle, AIPAC has been met with mounting resistance. The group has faced criticism over its stances on various issues, including the wars in Gaza and Iran.
Candidates endorsed by AIPAC have also faced tough opposition from both the political right and the political left for accepting the organization’s support and financial contributions as public opinion on the U.S. relationship with Israel has shifted. In order to tame the criticism, some AIPAC-endorsed candidates said they won’t accept any money from the organization. …”
My thoughts:
1. This was inevitable given how hard American public opinion has swung against Israel which now has a negative favorability rating in the United States.
2. The Israel Lobby isn’t going away. It is just adapting to these headwinds by trying to make campaign contributions and support for candidates more opaque.
3. It is still great news that Israel is so toxic that candidates have to run away from the Israel Lobby. The trend is toward greater awareness.
Source: https://occidentaldissent.com/2026/10/23/npr-aipac-halts-endorsements-and-direct-contributions-to-candidates/
Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.
"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.
Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world. Anyone can join. Anyone can contribute. Anyone can become informed about their world. "United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.
LION'S MANE PRODUCT
Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules
Mushrooms are having a moment. One fabulous fungus in particular, lion’s mane, may help improve memory, depression and anxiety symptoms. They are also an excellent source of nutrients that show promise as a therapy for dementia, and other neurodegenerative diseases. If you’re living with anxiety or depression, you may be curious about all the therapy options out there — including the natural ones.Our Lion’s Mane WHOLE MIND Nootropic Blend has been formulated to utilize the potency of Lion’s mane but also include the benefits of four other Highly Beneficial Mushrooms. Synergistically, they work together to Build your health through improving cognitive function and immunity regardless of your age. Our Nootropic not only improves your Cognitive Function and Activates your Immune System, but it benefits growth of Essential Gut Flora, further enhancing your Vitality.
Our Formula includes: Lion’s Mane Mushrooms which Increase Brain Power through nerve growth, lessen anxiety, reduce depression, and improve concentration. Its an excellent adaptogen, promotes sleep and improves immunity. Shiitake Mushrooms which Fight cancer cells and infectious disease, boost the immune system, promotes brain function, and serves as a source of B vitamins. Maitake Mushrooms which regulate blood sugar levels of diabetics, reduce hypertension and boosts the immune system. Reishi Mushrooms which Fight inflammation, liver disease, fatigue, tumor growth and cancer. They Improve skin disorders and soothes digestive problems, stomach ulcers and leaky gut syndrome. Chaga Mushrooms which have anti-aging effects, boost immune function, improve stamina and athletic performance, even act as a natural aphrodisiac, fighting diabetes and improving liver function. Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules Today. Be 100% Satisfied or Receive a Full Money Back Guarantee. Order Yours Today by Following This Link.

